Cargando…

Copper Binding and Redox Activity of α-Synuclein in Membrane-Like Environment

α-Synuclein (αSyn) constitutes the main protein component of Lewy bodies, which are the pathologic hallmark in Parkinson’s disease. αSyn is unstructured in solution but the interaction of αSyn with lipid membrane modulates its conformation by inducing an α-helical structure of the N-terminal region....

Descripción completa

Detalles Bibliográficos
Autores principales:	Bacchella, Chiara, Camponeschi, Francesca, Kolkowska, Paulina, Kola, Arian, Tessari, Isabella, Baratto, Maria Camilla, Bisaglia, Marco, Monzani, Enrico, Bubacco, Luigi, Mangani, Stefano, Casella, Luigi, Dell’Acqua, Simone, Valensin, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953312/ https://www.ncbi.nlm.nih.gov/pubmed/36830656 http://dx.doi.org/10.3390/biom13020287

Ejemplares similares

A Cu-bis(imidazole) Substrate Intermediate Is the Catalytically Competent Center for Catechol Oxidase Activity of Copper Amyloid-β
por: Bacchella, Chiara, et al.
Publicado: (2021)

Interaction and Redox Chemistry between Iron, Dopamine, and Alpha-Synuclein C-Terminal Peptides
por: Schifano, Fabio, et al.
Publicado: (2023)

Role of the Cysteine in R3 Tau Peptide in Copper Binding and Reactivity
por: Bacchella, Chiara, et al.
Publicado: (2022)

Oxidase Reactivity of Cu(II) Bound to N-Truncated Aβ Peptides Promoted by Dopamine
por: Bacchella, Chiara, et al.
Publicado: (2021)

Copper Ions and Parkinson’s Disease: Why Is Homeostasis So Relevant?
por: Bisaglia, Marco, et al.
Publicado: (2020)

α-Synuclein Toxicity in Drosophila melanogaster Is Enhanced by the Presence of Iron: Implications for Parkinson’s Disease
por: Agostini, Francesco, et al.
Publicado: (2023)

Leucine-rich repeat kinase 2 and alpha-synuclein: intersecting pathways in the pathogenesis of Parkinson's disease?
por: Greggio, Elisa, et al.
Publicado: (2011)

Covalent α-Synuclein Dimers: Chemico-Physical and Aggregation Properties
por: Pivato, Micaela, et al.
Publicado: (2012)

Copper Forms a PPII Helix-Like Structure with the Catalytic Domains of Bacterial Zinc Metalloproteases
por: Potok, Paulina, et al.
Publicado: (2023)

α-Synuclein Dimers Impair Vesicle Fission during Clathrin-Mediated Synaptic Vesicle Recycling
por: Medeiros, Audrey T., et al.
Publicado: (2017)

A Combined NMR and UV–Vis Approach to Evaluate Radical Scavenging Activity of Rosmarinic Acid and Other Polyphenols
por: Kola, Arian, et al.
Publicado: (2023)

Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies
por: Codolo, Gaia, et al.
Publicado: (2013)

Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease
por: Tassone, Giusy, et al.
Publicado: (2021)

Effects of Trehalose on Thermodynamic Properties of Alpha-synuclein Revealed through Synchrotron Radiation Circular Dichroism
por: Ruzza, Paolo, et al.
Publicado: (2015)

DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
por: Plotegher, N., et al.
Publicado: (2017)

Novel Perspective on Alzheimer’s Disease Treatment: Rosmarinic Acid Molecular Interplay with Copper(II) and Amyloid β
por: Kola, Arian, et al.
Publicado: (2020)

α-Synuclein overexpression increases dopamine toxicity in BE(2)-M17 cells
por: Bisaglia, Marco, et al.
Publicado: (2010)

Conformational Equilibria in Monomeric α-Synuclein at the Single-Molecule Level
por: Sandal, Massimo, et al.
Publicado: (2008)

Condition-Dependent Coordination and Peroxidase Activity of Hemin-Aβ Complexes
por: Bacchella, Chiara, et al.
Publicado: (2020)

Bioinorganic Chemistry of Micronutrients Related to Alzheimer’s and Parkinson’s Diseases
por: Kola, Arian, et al.
Publicado: (2023)

Interaction between Hemin and Prion Peptides: Binding, Oxidative Reactivity and Aggregation
por: Dell’Acqua, Simone, et al.
Publicado: (2020)

Parkinson’s disease and immune system: is the culprit LRRKing in the periphery?
por: Greggio, Elisa, et al.
Publicado: (2012)

Anti-Oxidants in Parkinson’s Disease Therapy: A Critical Point of View
por: Filograna, Roberta, et al.
Publicado: (2016)

Metformin Repurposing for Parkinson Disease Therapy: Opportunities and Challenges
por: Agostini, Francesco, et al.
Publicado: (2021)

Asymmetric Sulfoxidation by a Tyrosinase Biomimetic Dicopper Complex with a Benzimidazolyl Derivative of L-Phenylalanine
por: Lo Presti, Eliana, et al.
Publicado: (2023)

A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID β and Reduce In Vitro Neurotoxicity
por: Kola, Arian, et al.
Publicado: (2023)

Superoxide Dismutase (SOD)-mimetic M40403 Is Protective in Cell and Fly Models of Paraquat Toxicity: IMPLICATIONS FOR PARKINSON DISEASE
por: Filograna, Roberta, et al.
Publicado: (2016)

Superoxide Radical Dismutation as New Therapeutic Strategy in Parkinson’s Disease
por: De Lazzari, Federica, et al.
Publicado: (2018)

Impacts of increased α-synuclein on clathrin-mediated endocytosis at synapses: implications for neurodegenerative diseases
por: Medeiros, Audrey T., et al.
Publicado: (2018)

Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
por: Streubel-Gallasch, Linn, et al.
Publicado: (2021)

Extracellular clusterin limits the uptake of α‐synuclein fibrils by murine and human astrocytes
por: Filippini, Alice, et al.
Publicado: (2020)

Metal Complexes of Two Specific Regions of ZnuA, a Periplasmic Zinc(II) Transporter from Escherichia coli
por: Hecel, Aleksandra, et al.
Publicado: (2020)

Human SOD2 Modification by Dopamine Quinones Affects Enzymatic Activity by Promoting Its Aggregation: Possible Implications for Parkinson’s Disease
por: Belluzzi, Elisa, et al.
Publicado: (2012)

α-Synuclein Oligomers Induced by Docosahexaenoic Acid Affect Membrane Integrity
por: Fecchio, Chiara, et al.
Publicado: (2013)

Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation
por: Filograna, Roberta, et al.
Publicado: (2015)

DOPAL initiates αSynuclein-dependent impaired proteostasis and degeneration of neuronal projections in Parkinson’s disease
por: Masato, Anna, et al.
Publicado: (2023)

Hsc70 rescues the synaptic vesicle trafficking defects caused by α-synuclein dimers
por: Brady, Emily B., et al.
Publicado: (2023)

LRRK2 and neuroinflammation: partners in crime in Parkinson’s disease?
por: Russo, Isabella, et al.
Publicado: (2014)

Interaction of methotrexate, an anticancer agent, with copper(II) ions: coordination pattern, DNA-cleaving properties and cytotoxic studies
por: Nagaj, Justyna, et al.
Publicado: (2014)

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease
por: Bellucci, Arianna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nu3ioa3plgg054f9sn7spsski8